Search results

1. Exploring new roles for ADAR1 in cancer; generation of novel neoantigens, links with p53 and the effects of cancer treat…

Principal investigator: dr Małgorzata Kurkowiak

Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

Call: WEAVE-UNISONO, Panel: NZ2

2. SLC6A14 - an amino acid transporter upregulated in cancer: Role of chaperone proteins in transporter exit from endoplasm…

Principal investigator: prof. Katarzyna Anna Nałęcz

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 10, Panel: NZ3

3. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

Principal investigator: dr Daria Nawrocka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATINA 9, Panel: NZ6

4. New Hexokinase II inhibitors, in search of innovative therapeutic approaches to cancer treatment

Principal investigator: Mateusz Dawid Tomczyk

Politechnika Śląska, Wydział Chemiczny

Call: PRELUDIUM 14, Panel: NZ7

5. Targeting MMP-9 in Cancer Treatment: Computational Design and Experimental Validation of Potent, Safe Antitumor Agents

Principal investigator: dr Anna Żądło-Dobrowolska

Instytut Chemii Organicznej Polska Akademia Nauk

Call: SONATA BIS 15, Panel: ST5

6. New aryl difluoromethylenephosphonic acid and thiazole conjugates as effective PTP1B inhibitors used in the treatment of…

Principal investigator: Dominika Agnieszka Kołodziej-Sobczak

Uniwersytet Mikołaja Kopernika

Call: PRELUDIUM 24, Panel: ST5

7. Artificial intelligence in predicting treatment outcomes of abdominal cancers – implementation of machine learning and d…

Principal investigator: dr Krzysztof Bartnik

Politechnika Warszawska

Call: SONATINA 9, Panel: NZ7

8. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu…

Principal investigator: dr hab. Ewelina Piktel

Uniwersytet Medyczny w Białymstoku

Call: SONATA 20, Panel: NZ7

9. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu…

Principal investigator: dr Magdalena Wujak

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

Call: OPUS 26, Panel: NZ7

10. Advanced statistical and deep learning models to predict cancer risk and support treatment decisions

Principal investigator: dr Michał Marczyk

Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

Call: SONATA BIS 13, Panel: NZ2

11. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

Principal investigator: prof. Błażej Rubiś

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 25, Panel: NZ7

12. Multifunctional emulsion-based transporters for personalised cancer treatment

Principal investigator: prof. Ewa Dłuska

Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

Call: OPUS 25, Panel: ST8

13. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent…

Principal investigator: Olga Ciupak

Politechnika Gdańska, Wydział Chemiczny

Call: PRELUDIUM 20, Panel: NZ7

14. The [60]fullerene-based theranostic agent for pancreatic cancers treatment and diagnosis

Principal investigator: dr hab. Maciej Michał Serda

UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

Call: OPUS 18, Panel: NZ7

15. Liposomal berberine and anti-CD47 antibody as an effective therapy for the treatment of colorectal cancer

Principal investigator: dr Martyna Maria Mianowska

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: PRELUDIUM 17, Panel: NZ5

16. Molecular mechanism of action and therapeutic effect of 5-aza-2'-deoxycytidine and topoisomerase inhibitors combination …

Principal investigator: dr hab. Wojciech Kałas

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: OPUS 13, Panel: NZ5

17. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the colorectal cancer treatment

Principal investigator: prof. Adam Janusz Dziki

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: OPUS 12, Panel: NZ5

18. Association of selected, inherited genetic factors with the effectiveness of treatment in head and neck squamous cell ca…

Principal investigator: dr hab. Dorota Monika Butkiewicz

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

Call: OPUS 12, Panel: NZ5

19. Emerging spectroscopic technologies in diagnosis and treatment of cancer by Raman-IR-SNOM-AFM-femtosecond scpectroscopy-…

Principal investigator: prof. Halina Abramczyk

Politechnika Łódzka, Wydział Chemiczny

Call: OPUS 10, Panel: ST4

20. Co-dependence of cell-to-cell metabolite shuttles and macromolecular organization of metabolism in norm and pathology. Q…

Principal investigator: prof. Dariusz Stanisław Rakus

Uniwersytet Wrocławski, Wydział Nauk Biologicznych

Call: OPUS 10, Panel: NZ1

21. Study of the role of follicle stimulating hormone and its receptor in growth and putative treatment strategies for prost…

Principal investigator: Joanna Stelmaszewska

Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim

Call: PRELUDIUM 6, Panel: NZ5

22. The role of endogenous opioid system in the pathogenesis and treatment of inflammatory bowel diseases and colitis-associ…

Principal investigator: dr Marta Zielińska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: PRELUDIUM 6, Panel: NZ7

23. Influence of individual genetic host factors, associated with DNA damage, antioxidant defence, metastasis and angiogenes…

Principal investigator: dr hab. Dorota Butkiewicz

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii Instytut im. M Skłodowskiej–Curie Oddział w Gliwicach

Call: OPUS 3, Panel: NZ5

24. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

Principal investigator: Joanna Irena Szechyńska

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: PRELUDIUM 24, Panel: ST11

25. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen…

Principal investigator: prof. Ryszard Józef Ostaszewski

Instytut Chemii Organicznej Polska Akademia Nauk

Call: OPUS 25, Panel: NZ7

26. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

Principal investigator: dr Anna Katarzyna Florczak-Substyk

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATA 17, Panel: NZ7

27. Tryptophan Metabolites and their Metal Complexes as new drugs for Colorectal Cancer Treatment and Human Gut Microbiota R…

Principal investigator: prof. Beata Izabella Godlewska-Żyłkiewicz

Uniwersytet w Białymstoku, Wydział Chemii

Call: OPUS 20, Panel: ST4

28. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic…

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 19, Panel: NZ7

29. Modulation of exosome production to support anti-cancer treatment

Principal investigator: dr Liliana Monika Czernek

Centrum Badań Molekularnych i Makromolekularnych PAN

Call: OPUS 18, Panel: NZ7

30. Curcuminoid-polyphenol conjugates as potential therapeutics for urinary system cancer treatment

Principal investigator: prof. Tomasz Adam Gośliński

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: OPUS 18, Panel: NZ7

31. Combined urinary bladder cancer treatment with isothiocyanate-derived mercapturic acids and microtubule assembly modulat…

Principal investigator: dr Mateusz Psurski

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATA 13, Panel: NZ7

32. Identification of the mechanism of antineoplastic activity of metformin, as an experimental approach to improve cancer t…

Principal investigator: prof. Jerzy Aleksander Pałka

Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

Call: OPUS 13, Panel: NZ7

33. Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for …

Principal investigator: dr hab. Hanna Helena Piotrowska-Kempisty

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 12, Panel: NZ7

34. Description of platelets role in metastasis and evaluation of anti-platelet treatment efficacy in mice model of metastat…

Principal investigator: Elżbieta Buczek

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Call: PRELUDIUM 8, Panel: NZ7

35. Study on the mechanism of cancer cell growth inhibition by synergistic activation of p53 protein caused by combined trea…

Principal investigator: dr hab. Marek Rusin

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 6, Panel: NZ5

36. Effects of receptor action of L- and D-Lactate on cervical cancer cells. Lactate modulation of cell DNA repair response …

Principal investigator: dr Waldemar Wagner

Instytut Biologii Medycznej PAN

Call: OPUS 2, Panel: NZ4

37. Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.

Principal investigator: dr hab. Natalia Vydra

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 22, Panel: NZ5

38. Non-canonical Estrogen Receptor (ER) signalling in breast cancer progression

Principal investigator: prof. Rafał Sebastian Sądej

Gdański Uniwersytet Medyczny

Call: OPUS 28, Panel: NZ3

39. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

Principal investigator: dr Monika Kluzek

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: OPUS 26, Panel: NZ7

40. Precise molecular characterization of circulating tumour cells in patients with triple negative breast cancer using high…

Principal investigator: prof. Stefano Volinia

Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

Call: OPUS 24, Panel: NZ7

41. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

Principal investigator: Dawid Dariusz Dorna

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 21, Panel: NZ7

42. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an…

Principal investigator: Szymon Tomczak

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 20, Panel: NZ5

43. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

Uniwersytet Gdański, Wydział Chemii

Call: OPUS 21, Panel: NZ7

44. The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance…

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 3, Panel: NZ5

45. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden…

Principal investigator: Anna Krętowska-Grunwald

Uniwersytet Medyczny w Białymstoku

Call: PRELUDIUM 22, Panel: NZ5

46. Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for ne…

Principal investigator: Katarzyna Joanna Dziubek

Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

Call: PRELUDIUM 21, Panel: NZ1

47. Quantitative analysis of ultrasound scattered in the tissue. Application in assessing tumor response to chemotherapy in …

Principal investigator: prof. Jerzy Litniewski

Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

Call: OPUS 18, Panel: ST7

48. Development of new and more efficient treatment against mesothelioma utilizing oncolytic adenovirus armed with ICOS liga…

Principal investigator: dr Łukasz Kuryk

Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

Call: SONATINA 3, Panel: NZ7

49. Hypoxia in combinatory treatment of murine pancreatic tumor

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 15, Panel: NZ5

50. Preparation and investigation of multifunctional biomaterials based on nanoapatites for possible application in bone tum…

Principal investigator: dr Paulina Teresa Sobierajska

Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

Call: PRELUDIUM 14, Panel: ST5

Projects search